NCT05778201

Brief Summary

Baby Drink is a formula based on lutein, mixed with blueberry fermented liquid, vitamins and minerals. Lutein is an effective antioxidant to prevent retinal damage caused by blue light, but it cannot be produced in the human body and depends on dietary intake. Blueberry fermented liquid is rich in polyphenolic compounds with excellent antioxidant capacity and the potential to reduce oxidative damage to eye cells caused by ultraviolet rays. With the prevalence of 3C products, myopia patients are increasing year by year in various regions, and suffer from eye diseases or vision loss with different degrees of complications. In this study, the subjects were provided with Baby Drink and tracked the degree of visual fatigue by regular questionnaires, and measured for visual acuity, axial length and diopter. The aim of this study is to investigate the protection of Baby Drink on visual acuity and visual fatigue.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P75+ for early_phase_1

Timeline
Completed

Started Mar 2023

Shorter than P25 for early_phase_1

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 8, 2023

Completed
Same day until next milestone

Study Start

First participant enrolled

March 8, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

March 21, 2023

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2023

Completed
Last Updated

March 21, 2023

Status Verified

March 1, 2023

Enrollment Period

9 months

First QC Date

March 8, 2023

Last Update Submit

March 19, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Eye fatigue questionnaire

    1. Eye fatigue were evaluated according to The Ocular Surface Disease Index (OSDI) introduced in 1997 by the Outcomes Research Group (Allergan Inc., Irvine, CA). 2. Content including: (1) Eye swelling, (2) Eye soreness, (3) Photophobia, (4) Blurred vision, (5) Dry eye, (6) Foreign body sensation, (7) Tearing, (8) General discomfort related to eye fatigue. 3. Scores are expressed on a scale of 0-3. 0 = No symptoms , 1 = Occasionally (≤1 time/day), 2 = Sometimes (1-3 times/day), 3 = Frequently (\>3 times/day), a low score means less visual fatigue and better eye quality.

    1 month

  • Best vision test

    1. Visual acuity was tested with the Snellen Eye Test Chart and recorded with the score proposed by Snellen. 2. Subjects were asked to stand 20 feet away to observe the snellen E-chart and record the smallest visual mark. 3. Recording method: 20/20 (1.0) is defined as normal vision, lower than this score indicates that the subject has ametropia, and higher than this indicates that the subject's vision is higher than the general standard

    1 month

Study Arms (1)

Baby Drink group

EXPERIMENTAL

1 package/ day for 1 month

Biological: Baby Drink group

Interventions

1 packge (20 ml)/ day for 1 month

Baby Drink group

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 20 or over
  • Willing to participate in this study and sign the subject's consent form
  • Myopia less than 700 degrees

You may not qualify if:

  • Have consumed related eye care products in past 3 months
  • Those who have eye infection in the past 3 months
  • People who have been diagnosed with any eye diseases in past 3 months
  • Those who are allergic to cicadae

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Asia university

Taichung, 413, Taiwan

RECRUITING

MeSH Terms

Conditions

Myopia

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Study Officials

  • Hui Wen Lin, ph.D

    Asia University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Hui Wen Lin, ph.D

CONTACT

Tzu Chun Chen, Master

CONTACT

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Model Details: Baby Drink Intervention group
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

March 8, 2023

First Posted

March 21, 2023

Study Start

March 8, 2023

Primary Completion

December 15, 2023

Study Completion

December 15, 2023

Last Updated

March 21, 2023

Record last verified: 2023-03

Locations